Page last updated: 2024-11-07

penicillamine and Budd-Chiari Syndrome

penicillamine has been researched along with Budd-Chiari Syndrome in 1 studies

Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.

Budd-Chiari Syndrome: A condition in which the hepatic venous outflow is obstructed anywhere from the small HEPATIC VEINS to the junction of the INFERIOR VENA CAVA and the RIGHT ATRIUM. Usually the blockage is extrahepatic and caused by blood clots (THROMBUS) or fibrous webs. Parenchymal FIBROSIS is uncommon.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barthel, HR1
Hiepe, F1

Reviews

1 review available for penicillamine and Budd-Chiari Syndrome

ArticleYear
[Lupus erythematosus and liver diseases].
    Deutsche medizinische Wochenschrift (1946), 1995, Sep-15, Volume: 120, Issue:37

    Topics: Autoimmune Diseases; Budd-Chiari Syndrome; Chelating Agents; Hepatitis; Hepatitis, Chronic; Hepatole

1995